Sunday, November 1, 2026

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

North Korea’s Ideological Construction: Key to Strengthening the Party’s Revolution in 2026?

North Korea prioritizes ideological construction, emphasizing its role in party development and political leadership during the 9th Congress.

Korean Visitors Caught in Grand Canyon Graffiti Controversy!

Korean tourists have sparked controversy over defacing natural landmarks at the Grand Canyon National Park in Arizona, USA.

News1

Author's Latest

Hyundai Motor Group Recruits Former Samsung Executive to Lead Autonomous Driving AI Development

Hyundai Motor Group appoints Kwon Jeong-hyun as head of Autonomous Driving Development, enhancing its autonomous mobility technologies.

Samsung Medical Center English Website Wins Red Dot Design Award

Samsung Medical Center's English website won a Red Dot Award for its user-focused design and effective communication for international patients.

Seoul St. Mary’s Hospital Performs Korea’s First LLAMACORN Procedure for Repeat TAVI

South Korea performs its first LLAMACORN procedure to reduce coronary obstruction risk during repeat TAVI, aiding elderly patients.

Samsung Secures Major 2nm Semiconductor Orders: What This Means for AI and Future Tech

Samsung Electronics secures 2nm foundry orders, expecting a significant increase in demand from AI sector clients this year.

JP-2266: The Next-Gen Diabetes Treatment Revolutionizing Blood Sugar Control in Asia

Jeil Pharmaceutical's JP-2266 shows significant blood sugar improvement in phase II trials, with benefits in weight loss and cardiovascular health.

Unlocking Health: Yuhan Corporation Launches Glucobiotic Probiotic for Diabetes Management in Mexico

Yuhan Corporation launches Glucobiotic in Mexico, targeting diabetes with a probiotic backed by extensive research and local partnerships.

KAIST Unveils Breakthrough AI Security Framework: 134 Attack Types Detected!

KAIST's new AI safety tech, Stable-GipflowNet, uncovers vulnerabilities seven times better than previous methods, enhancing AI reliability.

Samsung Galaxy S26: How Chip Shortages Led to Historic Losses in Q2 2026

Samsung's Device eXperience division faces its first operating loss due to chipflation despite rising sales, impacted by soaring memory costs.

Revolutionary BluEX-C Cage: The Future of Complex Spine Surgery in 2026

L&K Biomed's BluEX-C cage successfully aids complex cervical spine surgery in the U.S., showcasing innovative surgical advancements.

AriBio Completes Global Phase 3 Trial of Alzheimer’s Drug AR1001, Awaits Topline Results

AriBio completes final patient follow-up in Phase 3 trial for Alzheimer's treatment AR1001, entering data analysis phase.

LSK Global PS Expands Beyond Korea, Leverages Data and AI to Build Global CRO Competitiveness

LSK Global PS enhances global competitiveness by expanding from clinical trials to strategic consulting and data-driven services.

How DIDEN Robotics is Revolutionizing Shipbuilding with the DIDEN Spider Robot

Diden Robotics seeks 100 billion KRW to expand its quadrupedal robot, the Diden Spider, targeting shipbuilding and humanoid robot markets.

Unlocking Cell Growth: How LARS1 Protein Transforms Nutritional Signals into Cancer Treatment Insights

KAIST researchers unveil how cells sense nutrients, linking it to mTORC1 activation, paving the way for targeted cancer therapies.

Anthropic Unveils Cost-Effective AI Model Claude Opus 5: How Does It Compare to GPT-5.6 Sol?

Anthropic's Claude Opus 5 offers cost-effective AI performance, surpassing rivals in coding tasks while maintaining competitive pricing.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.